Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Targeted Lipid Control in Very-high-risk Indian Patients: Expert Insights
Author(s): Kausik Ray , Upendra Kaul , Srinivasa Rao , et al Added: 5 months ago

Guidelines & Statements
AHA 25: HFpEF as an Adipose Tissue Disorder
Author(s): Milton Packer Added: 6 months ago
AHA Scientific Sessions 2025 - Dr Milton Packer (Baylor University Medical Center, US) joins us to discuss his novel unifying hypothesis that heart failure with preserved ejection fraction arises primarily from visceral adipose tissue dysfunction and altered adipokine signaling, rather than as a heterogeneous disorder driven by multiple comorbidities.Interview Questions:Can you explain the core… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Maternal Cardiac Function in Pregnancies With Metabolic Disorders
Author(s): Deesha Patel , Makrina D Savvidou Added: 1 year ago

Imaging & Diagnostics

Prevention & Chronic Conditions
30th Annual Meeting of the ISCP
Author(s): Jessica Ares-Blanco , Miguel García-Villarino , Carmen Lambert , et al Added: 1 month ago

Prevention & Chronic Conditions

Demographic
30th Annual Meeting of the ISCP
Author(s): Miguel García-Villarino , Elias Delgado , Carmen Lambert , et al Added: 1 month ago

Prevention & Chronic Conditions

Demographic
Lipid-lowering Therapies and Lp(a)
Author(s): Stephen Nicholls , Adam J Nelson Added: 1 month ago

Prevention & Chronic Conditions
AHA 24 Late-Breaking Discussion: The ZODIAC Trial
Author(s): Harriette Van Spall , Kausik Ray Added: 1 year ago
AHA Conference 2024 — Key findings from the ZODIAC trial investigating the role of a decision support system in optimising lipid-lowering therapy for ACS patients.Dr Harriette Van Spall (McMaster University, CA) sits down with Prof Kausik Ray (Imperial College London, UK) to discuss the findings from the randomized controlled ZODIAC trial assessing decision support systems (DSS) in optimising… View more

Prevention & Chronic Conditions

MI/ACS
Daniel Gaudet
Research Area(s) / Expertise:
Dr Daniel Gaudet founded the Université de Montréal Community Genomics Medicine Center, the Lipid Research Group and the Lipid Clinic at the Chicoutimi Hospital, where he was also director of research from 2003 to 2012.In 2000, Dr. Gaudet founded ECOGENE-21, a non-profit organisation in translational medicine and systems approach whose aim is the acquisition of new knowledge, the development and… View more
AHA 25: CRISPR-Cas9 Gene Editing Therapy Targeting ANGPTL3
Author(s): Stephen Nicholls Added: 7 months ago
AHA Scientific Sessions 2025 - Phase 1 results show the CRISPR-Cas9 gene editing therapy is a safe treatment option targeting ANGPTL3 in patients with lipid disorders.Prof Stephen Nicholls (Monash Victorian Heart Institute, Clayton, AU) joins us to share results from a first-in-human phase 1 trial investigating a one-time infusion of CTX310, a CRISPR-Cas9 gene editing therapy, at different doses… View more

Prevention & Chronic Conditions
Robert Eckel
Research Area(s) / Expertise: Job title: Professor of Medicine
Dr Robert Eckel is Professor of Medicine in the Division of Endocrinology, Metabolism and Diabetes at the University of Colorado Anschutz Medical Campus, Colorado, US.Dr Eckel has held appointments such as the Charles A. Boettcher II Endowed Chair in atherosclerosis research at the University of Colorado, director of the Lipid Clinic at University of Colorado Hospital, and program director of the… View more